Search Results - "Ojima, Hidenori"

Refine Results
  1. 1

    Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification by Kurebayashi, Yutaka, Ojima, Hidenori, Tsujikawa, Hanako, Kubota, Naoto, Maehara, Junki, Abe, Yuta, Kitago, Minoru, Shinoda, Masahiro, Kitagawa, Yuko, Sakamoto, Michiie

    Published in Hepatology (Baltimore, Md.) (01-09-2018)
    “…Immune cells constitute an important element of tumor tissue. Accumulating evidence indicates their clinicopathological significance in predicting prognosis…”
    Get full text
    Journal Article
  2. 2

    Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma by Arai, Yasuhito, Totoki, Yasushi, Hosoda, Fumie, Shirota, Tomoki, Hama, Natsuko, Nakamura, Hiromi, Ojima, Hidenori, Furuta, Koh, Shimada, Kazuaki, Okusaka, Takuji, Kosuge, Tomoo, Shibata, Tatsuhiro

    Published in Hepatology (Baltimore, Md.) (01-04-2014)
    “…Cholangiocarcinoma is an intractable cancer, with limited therapeutic options, in which the molecular mechanisms underlying tumor development remain poorly…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Genetic Alteration of Keap1 Confers Constitutive Nrf2 Activation and Resistance to Chemotherapy in Gallbladder Cancer by Shibata, Tatsuhiro, Kokubu, Akiko, Gotoh, Masahiro, Ojima, Hidenori, Ohta, Tsutomu, Yamamoto, Masayuki, Hirohashi, Setsuo

    Published in Gastroenterology (New York, N.Y. 1943) (01-10-2008)
    “…Background & Aims: Biliary tract cancer (BTC) is a highly malignant tumor, and identification of effective therapeutic targets to improve prognosis is urgently…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Characterization of spatial distribution of tumor-infiltrating CD8+ T cells refines their prognostic utility for pancreatic cancer survival by Masugi, Yohei, Abe, Tokiya, Ueno, Akihisa, Fujii-Nishimura, Yoko, Ojima, Hidenori, Endo, Yutaka, Fujita, Yusuke, Kitago, Minoru, Shinoda, Masahiro, Kitagawa, Yuko, Sakamoto, Michiie

    Published in Modern pathology (01-10-2019)
    “…The abundance of cytotoxic T-cell infiltrates has important implications for patient outcome and therapeutic design for pancreatic ductal adenocarcinoma…”
    Get full text
    Journal Article
  8. 8

    Lysine Demethylase LSD1 Coordinates Glycolytic and Mitochondrial Metabolism in Hepatocellular Carcinoma Cells by Sakamoto, Akihisa, Hino, Shinjiro, Nagaoka, Katsuya, Anan, Kotaro, Takase, Ryuta, Matsumori, Haruka, Ojima, Hidenori, Kanai, Yae, Arita, Kazunori, Nakao, Mitsuyoshi

    Published in Cancer research (Chicago, Ill.) (01-04-2015)
    “…The hallmark of most cancer cells is the metabolic shift from mitochondrial to glycolytic metabolism for adapting to the surrounding environment. Although…”
    Get full text
    Journal Article
  9. 9

    Silencing of microRNA‐122 is an early event during hepatocarcinogenesis from non‐alcoholic steatohepatitis by Takaki, Yoko, Saito, Yoshimasa, Takasugi, Azusa, Toshimitsu, Kohta, Yamada, Shoji, Muramatsu, Toshihide, Kimura, Masaki, Sugiyama, Kazuo, Suzuki, Hiromu, Arai, Eri, Ojima, Hidenori, Kanai, Yae, Saito, Hidetsugu

    Published in Cancer science (01-10-2014)
    “…Non‐alcoholic steatohepatitis (NASH) has emerged as a common cause of chronic liver disease and virus‐independent hepatocellular carcinoma (HCC) in patients…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Proteomic study of hepatocellular carcinoma using a novel modified aptamer-based array (SOMAscan™) platform by Qiao, Zhiwei, Pan, Xiaoqing, Parlayan, Cuneyd, Ojima, Hidenori, Kondo, Tadashi

    “…Vascular invasion is a pathological hallmark of hepatocellular carcinoma (HCC), associated with poor prognosis; it is strongly related to the early recurrence…”
    Get full text
    Journal Article
  12. 12

    FOXP3+ Regulatory T Cells Affect the Development and Progression of Hepatocarcinogenesis by KOBAYASHI, Noritoshi, HIRAOKA, Nobuyoshi, YAMAGAMI, Wataru, OJIMA, Hidenori, KANAI, Yae, KOSUGE, Tomoo, NAKAJIMA, Atsushi, HIROHASHI, Setsuo

    Published in Clinical cancer research (01-02-2007)
    “…Purpose: Tumor-infiltrating lymphocytes represent the host immune response to cancer. CD4 + CD25 + FOXP3 + regulatory T cells (Tregs) suppress the immune…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Establishment of various biliary tract carcinoma cell lines and xenograft models for appropriate preclinical studies by Ojima, Hidenori, Yamagishi, Seri, Shimada, Kazuaki, Shibata, Tatsuhiro

    Published in World journal of gastroenterology : WJG (28-10-2016)
    “…We recently reported several driver genes of biliary tract carcinoma(BTC) that are known to play important roles in oncogenesis and disease progression…”
    Get full text
    Journal Article
  15. 15

    Steatotic and nonsteatotic scirrhous hepatocellular carcinomas reveal distinct clinicopathological features by Hatano, Mami, Ojima, Hidenori, Masugi, Yohei, Tsujikawa, Hanako, Hiraoka, Nobuyoshi, Kanai, Yae, Shimada, Kazuaki, Shinoda, Masahiro, Sakamoto, Michiie

    Published in Human pathology (01-04-2019)
    “…We investigated the clinicopathological and molecular characteristics of scirrhous hepatocellular carcinoma (HCC) to elucidate its uniqueness. Samples from 120…”
    Get full text
    Journal Article
  16. 16

    PI3K-mTOR pathway identified as a potential therapeutic target in biliary tract cancer using a newly established patient-derived cell panel assay by Sakamoto, Yasunari, Yamagishi, Seri, Tanizawa, Yoshinori, Tajimi, Masaomi, Okusaka, Takuji, Ojima, Hidenori

    Published in Japanese journal of clinical oncology (01-04-2018)
    “…We evaluated four new molecular targeting agents using our cell line panel with 17 biliary tract carcinoma cell lines. PI3K/mTOR inhibitor showed promising…”
    Get full text
    Journal Article
  17. 17

    Precision pathology analysis of the development and progression of hepatocellular carcinoma: Implication for precision diagnosis of hepatocellular carcinoma by Ueno, Akihisa, Masugi, Yohei, Yamazaki, Ken, Kurebayashi, Yutaka, Tsujikawa, Hanako, Effendi, Kathryn, Ojima, Hidenori, Sakamoto, Michiie

    Published in Pathology international (01-03-2020)
    “…Outcomes for patients with hepatocellular carcinoma (HCC) remain poor because the condition is often unresponsive to the available treatments. Consequently,…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Clinical impact of c-Met expression and its gene amplification in hepatocellular carcinoma by Kondo, Shunsuke, Ojima, Hidenori, Tsuda, Hitoshi, Hashimoto, Jun, Morizane, Chigusa, Ikeda, Masafumi, Ueno, Hideki, Tamura, Kenji, Shimada, Kazuaki, Kanai, Yae, Okusaka, Takuji

    Published in International journal of clinical oncology (01-04-2013)
    “…Background c-Met is an oncogene encoding a receptor for hepatocyte growth factor and, as such, plays a key role in hepatocellular carcinomas (HCC). We…”
    Get full text
    Journal Article
  20. 20